FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (Nasdaq: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today announced that it has entered into an exclusive distribution agreement with SIAD Healthcare for sale of its SonicOne® Ultrasonic Wound Care System in Italy. Under the terms of the contract, SIAD has agreed to minimum purchase order provisions for the SonicOne for a term of three years, beginning September 30, 2007, and renewal thereafter upon mutual agreement by the companies.
